Drug Rebate Participation Recorded for Braintree Laboratories
Pharmaceutical and Therapeutics Committee | State of ConnecticutState · Hartford, CT- Document date
- Aug 6, 2026
- Term
- 02/01/2008 – 12/31/2299
- Renews
- Free account
The 30-second brief
Medicaid records BRAINTREE LABORATORIES INC. as participating in the HUSKY B drug rebate program beginning February 2008.
Braintree Laboratories Inc holds this contract with Pharmaceutical and Therapeutics Committee | State of Connecticut.
The renewal date is on record. Get free alerts for pre-RFPs like this one, matched to what you sell.
Get pre-RFPs for work like this before the bid is out.
Get pre-RFP alerts freeFree account · 30-second setup · No credit card
Contract details
- Document date
- August 6, 2026
- Term
- 02/01/2008 – 12/31/2299
- Renews
- On record
- Vendor
- Braintree Laboratories Inc
- Source document
- Medicaid Management Information System Report Drug Rebate Participation by Labeler Code 2026-08-06 (Report)
More Pharmaceutical and Therapeutics Committee | State of Connecticut contracts
Questions about this contract
Who was awarded the government contract by Pharmaceutical and Therapeutics Committee | State of Connecticut?
Braintree Laboratories Inc was awarded this government contract by Pharmaceutical and Therapeutics Committee | State of Connecticut, as recorded on August 6, 2026.
What type of contract is this?
This is a government contract, documented as a report record.
Where was this contract approved?
This contract appears in Medicaid Management Information System Report Drug Rebate Participation by Labeler Code 2026-08-06 (Report), dated August 6, 2026 from Pharmaceutical and Therapeutics Committee | State of Connecticut. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What is Pharmaceutical and Therapeutics Committee | State of Connecticut currently buying?
Explore Pharmaceutical and Therapeutics Committee | State of Connecticut's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.